Olivier Cussenot

27.1k total citations
437 papers, 10.8k citations indexed

About

Olivier Cussenot is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Olivier Cussenot has authored 437 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 241 papers in Pulmonary and Respiratory Medicine, 145 papers in Surgery and 107 papers in Molecular Biology. Recurrent topics in Olivier Cussenot's work include Prostate Cancer Treatment and Research (157 papers), Prostate Cancer Diagnosis and Treatment (133 papers) and Bladder and Urothelial Cancer Treatments (111 papers). Olivier Cussenot is often cited by papers focused on Prostate Cancer Treatment and Research (157 papers), Prostate Cancer Diagnosis and Treatment (133 papers) and Bladder and Urothelial Cancer Treatments (111 papers). Olivier Cussenot collaborates with scholars based in France, United Kingdom and United States. Olivier Cussenot's co-authors include Morgan Rouprêt, Georges Fournier, Éva Compérat, Géraldine Cancel‐Tassin, Philippe Berthon, Alain Latil, Antoine Valéri, Rosette Lidereau, Philippe Mangin and David Yates and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature reviews. Cancer.

In The Last Decade

Olivier Cussenot

420 papers receiving 10.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Cussenot France 57 4.8k 3.5k 3.5k 1.7k 1.5k 437 10.8k
Jan‐Erik Damber Sweden 49 4.1k 0.8× 2.3k 0.7× 1.2k 0.3× 1.7k 1.0× 795 0.5× 261 8.6k
Curtis A. Pettaway United States 52 3.3k 0.7× 2.2k 0.6× 3.5k 1.0× 2.9k 1.7× 1.7k 1.1× 264 10.1k
Arthur I. Sagalowsky United States 58 3.7k 0.8× 3.2k 0.9× 7.8k 2.2× 2.4k 1.4× 2.6k 1.8× 285 12.2k
Carl A. Olsson United States 52 5.5k 1.1× 2.2k 0.6× 2.3k 0.7× 1.4k 0.8× 2.0k 1.4× 236 9.8k
Markus A. Kuczyk Germany 47 7.1k 1.5× 5.3k 1.5× 3.3k 0.9× 1.8k 1.1× 1.0k 0.7× 281 11.3k
J. Brantley Thrasher United States 44 3.2k 0.7× 1.8k 0.5× 1.7k 0.5× 966 0.6× 950 0.6× 134 6.6k
George N. Thalmann Switzerland 67 5.6k 1.2× 3.3k 0.9× 8.2k 2.3× 3.7k 2.2× 3.6k 2.5× 323 15.9k
Fernando Augusto Soares Brazil 49 1.9k 0.4× 4.1k 1.2× 2.0k 0.6× 3.2k 1.9× 365 0.2× 405 9.8k
Chikara Οhyama Japan 43 2.6k 0.5× 3.5k 1.0× 3.0k 0.8× 2.2k 1.3× 809 0.6× 524 9.3k
Äkïhïko Okuyama Japan 50 1.7k 0.4× 3.3k 0.9× 1.9k 0.5× 860 0.5× 567 0.4× 479 9.4k

Countries citing papers authored by Olivier Cussenot

Since Specialization
Citations

This map shows the geographic impact of Olivier Cussenot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Cussenot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Cussenot more than expected).

Fields of papers citing papers by Olivier Cussenot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Cussenot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Cussenot. The network helps show where Olivier Cussenot may publish in the future.

Co-authorship network of co-authors of Olivier Cussenot

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Cussenot. A scholar is included among the top collaborators of Olivier Cussenot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Cussenot. Olivier Cussenot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Compérat, Éva, Shahrokh F. Shariat, Olivier Cussenot, & Johannes Kläger. (2025). Pathology of the upper urinary tract tumours: Histologic subtypes, genetics, biomarker testing. Histopathology. 88(1). 122–130.
2.
Cancel‐Tassin, Géraldine, et al.. (2023). Molecular Anatomy of Prostate Cancer and Its Implications in Active Surveillance and Early Intervention Strategies. SHILAP Revista de lepidopterología. 2(4). 300–319.
3.
Cussenot, Olivier, et al.. (2022). Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable?. British Journal of Urology. 130(5). 582–585. 1 indexed citations
4.
Cancel‐Tassin, Géraldine, et al.. (2021). Assessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up. World Journal of Urology. 39(9). 3329–3335. 21 indexed citations
5.
6.
Wendeu‐Foyet, Gaëlle, Sylvie Cénée, Yves Akoli Koudou, et al.. (2020). Circadian genes polymorphisms, night work and prostate cancer risk: Findings from the EPICAP study. International Journal of Cancer. 147(11). 3119–3129. 19 indexed citations
7.
Ngo, Carine, Olivier Cussenot, & Éva Compérat. (2020). Transurethral resection of bladder and radical cystectomy: Concordance of histology. Are we good enough?. SHILAP Revista de lepidopterología. 46(5). 354–359. 3 indexed citations
8.
Mozer, Pierre, Morgan Rouprêt, Chloé Le Cossec, et al.. (2015). First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer. HAL (Le Centre pour la Communication Scientifique Directe). 4 indexed citations
9.
10.
Rouprêt, Morgan, David Yates, Éva Compérat, & Olivier Cussenot. (2008). Upper Urinary Tract Urothelial Cell Carcinomas and Other Urological Malignancies Involved in the Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) Tumor Spectrum. European Urology. 54(6). 1226–1236. 133 indexed citations
11.
Oers, Johanna M.M. van, Ellen C. Zwarthoff, Ishtiaq Rehman, et al.. (2006). FGFR3 mutations have different effects on disease course in tumors from the bladder, ureter, and renal pelvis. Cancer Research. 66. 1059–1059.
12.
Rouprêt, Morgan & Olivier Cussenot. (2005). Carcinomes urothéliaux de la voie excrétrice supérieure: Nouveaux concepts pour la prise en charge. La Presse Médicale. 34(8). 601–607. 3 indexed citations
13.
Naïmi, Benyoussef, Alain Latil, Georges Fournier, et al.. (2002). Down‐regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate. The Prostate. 52(3). 245–252. 61 indexed citations
14.
Cancel‐Tassin, Géraldine, Alain Latil, Antoine Valéri, et al.. (2001). PCAP is the major known prostate cancer predisposing locus in families from south and west Europe. European Journal of Human Genetics. 9(2). 135–142. 43 indexed citations
15.
Brun, G, Hany Soliman, Jean‐Marie Villette, et al.. (1999). UPREGULATION OF ENDOTHELIN 1 AND ITS PRECURSOR BY IL-1β, TNF-α, and TGF-β IN THE PC3 HUMAN PROSTATE CANCER CELL LINE. Cytokine. 11(2). 157–162. 46 indexed citations
16.
Mourah, Samia, Olivier Cussenot, François Desgrandchamps, et al.. (1998). Assessment of microsatellite instability in urine in the detection of transitional‐cell carcinoma of the bladder. International Journal of Cancer. 79(6). 629–633. 3 indexed citations
17.
Degeorges, Armelle, Françoise Hoffschir, Olivier Cussenot, et al.. (1995). Recurrent cytogenetic alterations of prostate carcinoma and amplification of c‐myc or epidermal growth factor receptor in subclones of immortalized pnt1 human prostate epithelial cell line. International Journal of Cancer. 62(6). 724–731. 45 indexed citations
18.
Latil, Alain, et al.. (1994). Oncogene amplifications in early‐stage human prostate carcinomas. International Journal of Cancer. 59(5). 637–638. 31 indexed citations
19.
Desgrandchamps, F., et al.. (1992). [Prostatic growth factors and benign hypertrophy of the prostate. Current knowledge and perspectives].. PubMed. 2(6). 1031–44. 3 indexed citations
20.
Desgrandchamps, François, Roger Tatoud, Olivier Cussenot, et al.. (1992). Facteurs de croissance prostatiques et hypertrophie bénigne de la pr ostate Etat des connaissances actuelles et perspectives. Progrès en Urologie. 2(6). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan‐Erik Damber Breakdown of academic impact, for papers by Curtis A. Pettaway Breakdown of academic impact, for papers by Arthur I. Sagalowsky Breakdown of academic impact, for papers by Carl A. Olsson Breakdown of academic impact, for papers by Markus A. Kuczyk Breakdown of academic impact, for papers by J. Brantley Thrasher Breakdown of academic impact, for papers by George N. Thalmann Breakdown of academic impact, for papers by Fernando Augusto Soares Breakdown of academic impact, for papers by Chikara Οhyama Breakdown of academic impact, for papers by Äkïhïko Okuyama
Rankless by CCL
2026